These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 9511045)

  • 61. Identification of reduced fluoroquinolone susceptibility in Escherichia coli: a herald for emerging resistance.
    Chen FJ; McDonald LC; Ho M; Lo HJ
    J Antimicrob Chemother; 2001 Dec; 48(6):936-8. PubMed ID: 11733487
    [No Abstract]   [Full Text] [Related]  

  • 62. Cloning of organic solvent tolerance gene ostA that determines n-hexane tolerance level in Escherichia coli.
    Aono R; Negishi T; Nakajima H
    Appl Environ Microbiol; 1994 Dec; 60(12):4624-6. PubMed ID: 7811102
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Emergence of fluoroquinolone-resistant Escherichia coli in fecal flora of cancer patients receiving norfloxacin prophylaxis.
    Carratala J; Fernandez-Sevilla A; Tubau F; Dominguez MA; Gudiol F
    Antimicrob Agents Chemother; 1996 Feb; 40(2):503-5. PubMed ID: 8834911
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Cell surface properties of organic solvent-tolerant mutants of Escherichia coli K-12.
    Aono R; Kobayashi H
    Appl Environ Microbiol; 1997 Sep; 63(9):3637-42. PubMed ID: 9293016
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Fluoroquinolone carboxylic acids: is research on the development of resistance becoming invalidated?].
    Wiedemann B; Heisig P
    Pharm Unserer Zeit; 1993 Nov; 22(5-6):286-95. PubMed ID: 8121930
    [No Abstract]   [Full Text] [Related]  

  • 66. Analysis of organic solvent tolerance in Escherichia coli using gene expression profiles from DNA microarrays.
    Hayashi S; Aono R; Hanai T; Mori H; Kobayashi T; Honda H
    J Biosci Bioeng; 2003; 95(4):379-83. PubMed ID: 16233423
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The Future of Microbial Drug Resistance.
    Boneca IG
    Microb Drug Resist; 2021 Jan; 27(1):1-2. PubMed ID: 33464170
    [No Abstract]   [Full Text] [Related]  

  • 68. Increasing Solvent Tolerance to Improve Microbial Production of Alcohols, Terpenoids and Aromatics.
    Schalck T; Bergh BVD; Michiels J
    Microorganisms; 2021 Jan; 9(2):. PubMed ID: 33530454
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A Novel Regulatory Cascade Involving BluR, YcgZ, and Lon Controls the Expression of
    Duval V; Foster K; Brewster J; Levy SB
    Front Microbiol; 2017; 8():1148. PubMed ID: 28713335
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Greater ciprofloxacin tolerance as a possible selectable phenotype underlying the pandemic spread of the H30 subclone of Escherichia coli sequence type 131.
    Johnson JR; Porter SB; Thuras P; Johnson TJ; Price LB; Tchesnokova V; Sokurenko EV
    Antimicrob Agents Chemother; 2015 Nov; 59(11):7132-5. PubMed ID: 26324269
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Intensity and Mechanisms of Fluoroquinolone Resistance within the H30 and H30Rx Subclones of Escherichia coli Sequence Type 131 Compared with Other Fluoroquinolone-Resistant E. coli.
    Johnson JR; Johnston B; Kuskowski MA; Sokurenko EV; Tchesnokova V
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4471-80. PubMed ID: 25987621
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria.
    Li XZ; Plésiat P; Nikaido H
    Clin Microbiol Rev; 2015 Apr; 28(2):337-418. PubMed ID: 25788514
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Characterization of RarA, a novel AraC family multidrug resistance regulator in Klebsiella pneumoniae.
    Veleba M; Higgins PG; Gonzalez G; Seifert H; Schneiders T
    Antimicrob Agents Chemother; 2012 Aug; 56(8):4450-8. PubMed ID: 22644028
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Extremophiles: from abyssal to terrestrial ecosystems and possibly beyond.
    Canganella F; Wiegel J
    Naturwissenschaften; 2011 Apr; 98(4):253-79. PubMed ID: 21394529
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The prevalence of fluoroquinolone resistance mechanisms in colonizing Escherichia coli isolates recovered from hospitalized patients.
    Lautenbach E; Metlay JP; Mao X; Han X; Fishman NO; Bilker WB; Tolomeo P; Wheeler M; Nachamkin I
    Clin Infect Dis; 2010 Aug; 51(3):280-5. PubMed ID: 20597679
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Escherichia coli mar and acrAB mutants display no tolerance to simple alcohols.
    Ankarloo J; Wikman S; Nicholls IA
    Int J Mol Sci; 2010 Mar; 11(4):1403-12. PubMed ID: 20480026
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Complete genome sequence of the N2-fixing broad host range endophyte Klebsiella pneumoniae 342 and virulence predictions verified in mice.
    Fouts DE; Tyler HL; DeBoy RT; Daugherty S; Ren Q; Badger JH; Durkin AS; Huot H; Shrivastava S; Kothari S; Dodson RJ; Mohamoud Y; Khouri H; Roesch LF; Krogfelt KA; Struve C; Triplett EW; Methé BA
    PLoS Genet; 2008 Jul; 4(7):e1000141. PubMed ID: 18654632
    [TBL] [Abstract][Full Text] [Related]  

  • 78. mgtA Expression is induced by rob overexpression and mediates a Salmonella enterica resistance phenotype.
    Barchiesi J; Castelli ME; Soncini FC; Véscovi EG
    J Bacteriol; 2008 Jul; 190(14):4951-8. PubMed ID: 18487336
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Mutation rate and evolution of fluoroquinolone resistance in Escherichia coli isolates from patients with urinary tract infections.
    Komp Lindgren P; Karlsson A; Hughes D
    Antimicrob Agents Chemother; 2003 Oct; 47(10):3222-32. PubMed ID: 14506034
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The periplasmic protein MppA requires an additional mutated locus to repress marA expression in Escherichia coli.
    Bina X; Perreten V; Levy SB
    J Bacteriol; 2003 Feb; 185(4):1465-9. PubMed ID: 12562820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.